All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over. n.pr/44iEj4N
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: NPR (@npr.org)
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: NPR (@npr.org)